AL-S Pharma AG
Biotechnology Research / BiopharmaceuticalPatients with amyotrophic lateral sclerosis (ALS)
AL-S Pharma AG is a Swiss AG registered in Schlieren, ZH. Its registered activity falls under Manufacture of pharmaceutical preparations.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~6Officers8Active Relations8Deleted Relations0SOGC Records4First Record19.09.2016Latest Activity14.12.2020BiotechnologyClinical-stageALSDrug DevelopmentAntibody Therapy
Registry Information
c/o address
- Swiss UID
- CHE-302.525.568
- Legal Name
- AL-S Pharma AG
- Legal Form
- Limited or corporation
- Incorporated
- 19 Sept 2016
- Share Capital
- CHF 209'996.00
- Canton
- ZH
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Manufacture of pharmaceutical preparations
CMANUFACTURING21Manufacture of basic pharmaceutical products and pharmaceutical preparations212Manufacture of pharmaceutical preparations2120Manufacture of pharmaceutical preparations212000
Industry Health
Registered Address
c/o Neurimmune AG
8952, Schlieren, ZH
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Patients with amyotrophic lateral sclerosis (ALS)
Sources (4)
AL-S Pharma Reports Positive Results from Phase 2 Study of AP-101 for the Treatment of ALS, Supporting Plans for a Confirmatory Phase 3 Study – AL-S PHARMA
al-spharma.com
AL-S Pharma to present at the upcoming J. P. Morgan 2026 Annual Healthcare Conference on Thursday, January 15
prnewswire.com
SHAB Entries · Mercury-Reports
mercury-reports.com
AL-S Pharma AG · Mercury-Reports
mercury-reports.com